RegeniTherix - Study of Markers of Wound Healing 1.1
Research type
Research Study
Full title
RegeniTherix - Study of Markers of Wound Healing 1.1
IRAS ID
184481
Contact name
Alex Knight
Contact email
Sponsor organisation
Leeds Teaching Hospitals NHS Trust
Duration of Study in the UK
2 years, 0 months, 1 days
Research summary
The ultimate aim of our research is to develop a new wound dressing and device that will enable doctors and nurses looking after patients with open, nonhealing
diabetic foot wounds to know how well they are healing and if there are
any issues that might cause them to heal slowly.
Before such a dressing and device can be developed, we need to understand what molecules are produced, in what order and what they mean in terms of how the wound is healing or what other medical conditions may be affecting it.
In the original study we obtained fluid and samples of small numbers of cells from the surface of wounds to see what biomarkers can be obtained from these samples and as the wound heals see how the levels and pattern of the biomarkers change.
We have analysed 90 out of 180 sets of samples. We need further time to complete the analysis on all samples.REC name
North of Scotland Research Ethics Committee 1
REC reference
15/NS/0065
Date of REC Opinion
6 Jul 2015
REC opinion
Favourable Opinion